Projects

Homepage / Projects

All Projects / Biomechanics, biomedical engineering and physics of complex systems / Cardiovascular Physiology / Hematology and Stem Cells / Immunology / Medical Entomology / Microbiology and Parasitology / Molecular Oncology / Neuroendocrinology / Neuroscience / Nutrition and Metabolism / Nutritional Biochemistry And Dietology

Search projects by keyword

All Projects

Filter by

Cost International Projects National Projects Bilateral Scientific Cooperation Национални пројекти HORIZON-RIA ИДЕЈЕ позив

Synergistic education of parents with children with special needs

The project aims to empower parents/caregivers of children with special needs in daily life, improve their parental skills and social inclusion, health and quality of life. Objectives are to use innovative educational approach for improving parental skills in dealing with children with special needs, with a newly created comprehensive training curiculum and materials and online platform for continuous e-learning in line with the parents’ individual needs and expectations.

Тип пројекта:

International Projects

Anti-inflammatory dietary intervention in breast cancer patients receiving aromatase inhibitors

Project leader: Vesna Vučić

Project collaborators:

Danijela Ristić Medić, Aleksandra Arsić, Maja Milošević, Snježana Petrović, Nebojša Ivanović, Milica Kojadinović, Biljana Pokimica, Marija Paunović

Project number: 5050

Duration of the project: 2023 – 2026.

Leading Institution:

Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Serbia

Project Description:

The project is designed as a randomized clinical trial aimed to evaluate the efficacy of the anti-inflammatory nutritional intervention (in form of tailored diet or supplements) in managing nutritional status, clinical outcomes, and quality of life in breast cancer patients receiving aromatase inhibitors. The implementation of this project will help BRC patients to prevent the decline in nutritional status, to better tolerate the therapy, decrease side effects and risks of comorbidities, and thereby improve quality of life, clinical outcomes and survival rates.

Тип пројекта:

National Projects

Towards аn International Network for Evidence-based Research in Clinical Health Research,

Project leader: Prof Hans Lund PT. PhD,

Project collaborators:

Member of the Management Committee of the action Vesna Vučić, Ph.D., deputy member Danijela Ristić-Medić, Ph.D. sci med

Project number: CA17117

Duration of the project: October 2018-April 2023

Leading Institution: Department of Mental Health Western Norway University of Applied Sciences, Univerzitet u Bergenu, Norveška

Description of the project:

Redundant clinical research has been published due to the absent use of systematic reviews (SR) when new research is planned. It is unethical, limits the available funding for important and relevant research, and diminishes the public’s trust in research. In order to raise awareness of this inappropriate practice, the EVBRES-consortium define “Evidence-Based Research” (EBR) as the use of prior research in a systematic and transparent way to inform a new study so that it answers the questions that matter in a valid, efficient and accessible manner. New studies should be informed by SRs as to the most appropriate design and methods. EVBRES will establish an international European-based network aiming to raise awareness of the need to use of SRs when planning new studies and when placing new results in context. PhD students and senior clinical researchers’ needs to learn how to find, critically appraise and update a SR, answering the same clinical question the new study plans to answer. Closely related to this is the involvement and awareness of related stakeholders, including patients, ethics committees, funding agencies and scientific journals, to require SRs before approval of new clinical studies. By acknowledging and implementing an EBR approach these stakeholders can improve their own practice and can increase the incentives for clinical researchers to use an EBR approach. Further, EVBRES will catalyse more efficient updating and production of SRs, and monitor the implementation of an EBR approach both in clinical research and among related stakeholders.

Тип пројекта:

Cost

Prospective European Drug-Induced Liver Injury Network

Project leader : Prof Raul Andrede

Project collaborators: Vesna Vučić, Snježana Petrović

Project number: CA17112

Duration of the project: 16/10/2018 – 15/04/2023

Leading Institution:

FUNDACION PUBLICA ANDALUZA PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD, Calle Doctor Miguel Diaz Recio, 28 local Spain, 29010 Malaga

Description of the project:

The objectives of the PRO-EURO-DILI-NET Cost Action are to create a unique, co-operative, interdisciplinary European-based DILI network of stakeholders to co-ordinate efforts in DILI, to facilitate bi-directional exchange of discovered knowledge and generated hypotheses among different disciplines, and to promote clinically impactful knowledge discovery and its translation into clinical practice. The network will promote and coordinate a highly translational and innovative research program in Europe and beyond with the ultimate goal to pre-empt and prevent DILI, develop innovative therapeutic approaches that could improve clinical outcomes and enhance public awareness, while developing a forum for knowledge exchange and training of young European researches.

Тип пројекта:

Cost

Pan-European Network in Lipidomics and EpiLipidomics

Project leader : Dr Rosário Domingues

Project collaborators:

Snježana Petrović, Aleksandra Arsić, Vesna Vučić, Danijela Ristić-Medić, Marija Paunović, Milica Kojadinović

Project number: CA19105

Duration of the project: 13/10/2020 – 12/10/2024

Leading Institution:

University of Aveiro, Department of Chemistry, Campus Santiago, Portugal, 3810-193, Aveiro

Description of the project:

EpiLipidNET aims to build and maintain a multidisciplinary pan-European network of researchers, clinicians and enterprises working in the field of lipidomics and epilipidomics to boost a hub of research excellence, advanced knowledge and technology transfer, to promote high level of training for young researches and facilitate clinical translation. EpiLipidNet will include five interactive Working Groups covering analytical methods and computational approaches in (epi)Lipidomics, clinical significance and applications, lipid signaling and mechanisms of action, dissemination and outreach.

Тип пројекта:

Cost

Personalized Nutrition in aging society: redox control of major age-related diseases

Project leader : Mustapha Cherkaoui

Project collaborators: Vesna Vučić

Project number: CA16112

Duration of the project: October 2016 – October 2021

Leading Institution:

Laboratoire de Biochimie du Peroxysome, Inflammation et Métabolisme Lipidique Université de Bourgogne, France

Description of the project:

Тип пројекта:

Cost

Implementation Network Europe for Cancer Survivorship Care

Project leader : Prof Josephine Hegarty

Project collaborators: Vesna Vučić

Project number: CA21152

Duration of the project: October 2022 – October 2026

Leading Institution:

University College Cork,Brookfield Health Sciences Complex, College Road, Ireland

Description of the project:

Тип пројекта:

Cost

Interindividual variation in response to consumption of plant food bioactives and determinants involved

Project leader : Dr. Christine MORAND

Project collaborators:

Dr Aleksandra Konić Ristić, dr Marija Glibetić, dr Manja Zec, dr Nevena Vidović, dr Irena Krga, dr Biljana Pokimica

Project number: FA 1403

Duration of the project: 2014-2018

Leading Institution: INRAE – France

Description of the project:

Cardiovascular and metabolic diseases can be prevented, delayed or reduced by improving our eating habits. Increasing the consumption of plant foods rich in a range of compounds with potential beneficial effects (‘bioactive compounds’) is an important strategy to fight these chronic diseases. However, the translation of many promising preclinical results into human clinical trials has so far proven challenging mostly due to the large heterogeneity in individuals’ responsiveness to the intake of these compounds. Building a European multidisciplinary network, POSITIVe specifically addressed this issue by tackling: 1) the between-subjects variability in human absorption and metabolism of these compounds (working group, WG1); 2) the variability in the response (bioactivity) of humans to the intake of these compounds (WG2) and 3) the translation of the results from WG1 and WG2 into applications relevant to the scientific community, food industry, public health regulatory authorities, health care professionals an

Тип пројекта:

Cost

1 2